These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 3010079

  • 21. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
    LeBon TR, Kasuya J, Paxton RJ, Belfrage P, Hockman S, Manganiello VC, Fujita Yamaguchi Y.
    Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
    [Abstract] [Full Text] [Related]

  • 22. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
    Yu H, Cai JJ, Lee HC.
    Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893
    [Abstract] [Full Text] [Related]

  • 23. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.
    Martins TJ, Mumby MC, Beavo JA.
    J Biol Chem; 1982 Feb 25; 257(4):1973-9. PubMed ID: 6276403
    [Abstract] [Full Text] [Related]

  • 24. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
    Binah O, Sodowick B, Vulliemoz Y, Danilo P, Rosen M.
    Circulation; 1986 Mar 25; 73(3 Pt 2):III46-51. PubMed ID: 3002663
    [Abstract] [Full Text] [Related]

  • 25. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.
    Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML.
    J Pharmacol Exp Ther; 1987 Sep 25; 242(3):864-72. PubMed ID: 2821228
    [Abstract] [Full Text] [Related]

  • 26. Pharmacology of bipyridine phosphodiesterase III inhibitors.
    Honerjäger P, Nawrath H.
    Eur J Anaesthesiol Suppl; 1992 Sep 25; 5():7-14. PubMed ID: 1600969
    [Abstract] [Full Text] [Related]

  • 27. Characterization of two recombinant PDE3 (cGMP-inhibited cyclic nucleotide phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts and Sf9 insect cells.
    Leroy MJ, Degerman E, Taira M, Murata T, Wang LH, Movsesian MA, Meacci E, Manganiello VC.
    Biochemistry; 1996 Aug 06; 35(31):10194-202. PubMed ID: 8756484
    [Abstract] [Full Text] [Related]

  • 28. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
    Endoh M, Yamashita S, Taira N.
    J Pharmacol Exp Ther; 1982 Jun 06; 221(3):775-83. PubMed ID: 6283063
    [Abstract] [Full Text] [Related]

  • 29. Cardiac cGMP-stimulated cyclic nucleotide phosphodiesterases: effects of cGMP analogues and drugs.
    Komas N, Le Bec A, Stoclet JC, Lugnier C.
    Eur J Pharmacol; 1991 Jan 25; 206(1):5-13. PubMed ID: 1648496
    [Abstract] [Full Text] [Related]

  • 30. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS, Bowling N, Boder GB, Kauffman R.
    J Pharmacol Exp Ther; 1984 Jul 25; 230(1):124-32. PubMed ID: 6086873
    [Abstract] [Full Text] [Related]

  • 31. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone.
    Earl CQ, Linden J, Weglicki WB.
    J Cardiovasc Pharmacol; 1986 Jul 25; 8(4):864-72. PubMed ID: 2427830
    [Abstract] [Full Text] [Related]

  • 32. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
    Robichon A.
    J Cell Biochem; 1991 Oct 25; 47(2):147-57. PubMed ID: 1661738
    [Abstract] [Full Text] [Related]

  • 33. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
    Sabatine JM, Coffee CJ.
    Arch Biochem Biophys; 1986 Aug 15; 249(1):95-105. PubMed ID: 3017224
    [Abstract] [Full Text] [Related]

  • 34. [cGMP-activated phosphodiesterase from human brain: kinetic and regulatory properties].
    Bobruskin ID, Medvedeva MV, Severin ES.
    Biokhimiia; 1991 Jun 15; 56(6):999-1010. PubMed ID: 1657216
    [Abstract] [Full Text] [Related]

  • 35. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase.
    Fisher DA, Smith JF, Pillar JS, St Denis SH, Cheng JB.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):570-7. PubMed ID: 9618252
    [Abstract] [Full Text] [Related]

  • 36. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS, Rybalkin SD.
    Cell Biochem Funct; 1986 Jul 29; 4(3):205-11. PubMed ID: 3015450
    [Abstract] [Full Text] [Related]

  • 37. Purification and characterization of calmodulin-dependent functional protein, phosphodiesterase, in the lens.
    Yamamoto T, Iwata S.
    Jpn J Ophthalmol; 1987 Jul 29; 31(4):570-81. PubMed ID: 2834593
    [Abstract] [Full Text] [Related]

  • 38. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC, Shih CM, Lai YH, Chen JH, Huang HL.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2087-94. PubMed ID: 15476679
    [Abstract] [Full Text] [Related]

  • 39. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand.
    Degerman E, Belfrage P, Newman AH, Rice KC, Manganiello VC.
    J Biol Chem; 1987 Apr 25; 262(12):5797-807. PubMed ID: 3032944
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.